Respiratory Disease News

Medindia's Press Release’ section provides the latest press release on Respiratory Disease from across the world for the global audience. This page links to 843 Respiratory Disease press releases.

QFG Asks WHO to Consider the Lives of a Billion Smokers in Panama Talks

MANILA, Philippines , Jan. 29, 2024 /PRNewswire/ -- Consumer advocacy group Quit for Good asked the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) to consider the lives of more than a billion smokers when it ...

National Non-Smoking Week: Canada can be smoke free by 2035

Acceptance of harm reduction, education and open dialogue are the keys to succeed MONTREAL , Jan. 22, 2024 /CNW/ - At the start of National Non-Smoking Week, Imperial Tobacco Canada (ITCAN) urges governments and public health ...

E-Cigarettes not a gateway to smoking, helps reduce tobacco usage in population

E-Cigarette use has fallen from 14% in 2022 to 10% in 2023, among high school students in US, while cigarette use remained at an all-time low, reveals CDC & FDA Survey NEW DELHI , Jan. 17, 2024 /PRNewswire/ -- A recent study ...

Statement from the Chief Public Health Officer of Canada on Respiratory Illness Season

OTTAWA, ON , Dec. 14, 2023 /CNW/ - Respiratory illness season is well underway in Canada . While respiratory infections can occur year-round, it is common to see a significant increase in the fall and winter months. For some areas where ...

Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis

Chiesi Group and Haisco Pharmaceutical will collaborate closely to develop HSK31858, a novel reversible dipeptidyl peptidase 1 (DPP1) inhibitor for respiratory diseases. This agreement expands Chiesi's comprehensive R&D program in ...

Understanding Survival Factors in Critically Ill Patients on Extracorporeal Membrane Oxygenation

Scientists from Korea have identified the factors associated with in-hospital mortality in critically ill patients requiring extracorporeal membrane oxygenation SEOUL , Nov. 17, 2023 /PRNewswire/ -- Extracorporeal membrane ...

Bridge Biotherapeutics Announces Positive Recommendation from the Independent Data Monitoring Committee of the BBT-877 Phase 2a Study in Idiopathic Pulmonary Fibrosis

The independent data monitoring committee (IDMC) recommended the continuation of the BBT-877 Phase 2 a trial based on the initial clinical data from the first 20 participants dosed with the investigational product No safety concerns ...

REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices MARLBOROUGH, Mass. , Oct. 24, 2023 /PRNewswire/ -- Data from the REAL-PE study was ...

Quit For Good Urges the FDA and WHO to Help Adult Smokers

MANILA, Philippines , Oct. 16, 2023 /PRNewswire/ -- Quit For Good, a non-profit organization promoting harm reduction in the Philippines , lauded the United States' intensified campaign on preventing the youth from consuming nicotine ...

Novel classification of allergic disorders published by the European Academy of Allergy and Clinical Immunology: SIAF

Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper published in 'Allergy' DAVOS, Switzerland , Oct. 10, 2023 /PRNewswire/ -- The revision of the current allergic ...

First
Prev
1
2
3
4
5
6
7
8
9
10
Next
Last